Clinical Study of Shenhong Tongluo Recipe in Treating Carotid Atherosclerosis-Reference-Cited by-同舟云学术

Clinical Study of Shenhong Tongluo Recipe in Treating Carotid Atherosclerosis

Published:2024-01-01 Issue:1 Volume:9 Page:
ISSN:2444-8656
Container-title:Applied Mathematics and Nonlinear Sciences
language:en
Short-container-title:

Author:

Zhang Linlin¹,Wei Qian²,Wang Meiling¹,Li Peize³,Chen Ying⁴

Affiliation:

1. College of Traditional Chinese Medicine , Changchun University of Chinese Medicine , Changchun , Jilin , , China .

2. Cardiac Rehabilitation Department , The Third Affiliated Hospital of Changchun University of Chinese Medicine , Changchun , Jilin , , China .

3. Department of Orthopedics , Changchun Chinese Medicine Hospital , Changchun , Jilin , , China .

4. Department of Cardiology , The Affiliated Hospital to Changchun University of Chinese Medicine , Changchun , Jilin , , China .

Abstract

Abstract To observe the clinical effect of Shenhong Tongluo Recipe on carotid atherosclerosis. Method: 72 patients were randomly divided into a control group (36 cases) and an experimental group (36 cases). The control group received atorvastatin calcium, while the experimental group received the Shenhong Tongluo formula. The treatment program consisted of 24 weeks. Observe the thickness of the intima media and plaque area of the carotid artery; Hs CRP, MLR (mononuclear C/lymphoid C), NLR (neutrophil C/lymphoid C); Clinical efficacy of traditional Chinese medicine and TCM syndrome score; Measurement of blood lipid levels (TG, TC, HDL, LDL); Homocysteine and uric acid; Changes in safety indicators. The total effective rate of the experimental group was higher than that of the control group (P<0.05). After treatment, the carotid intima-media thickness and plaque area in the experimental group; Hs CRP, MLR (mononuclear C/lymphoid C), NLR (neutrophil C/lymphoid C); Clinical efficacy of traditional Chinese medicine and TCM syndrome score; Blood lipid levels (TG, TC, LDL); Homocysteine and uric acid levels decreased (P<0.05), and the traditional Chinese medicine syndrome score was lower than that of the control group (P<0.05). No significant adverse reactions were observed in the experimental group’s control group. Conclusion Shenhong Tongluo Recipe can safely and effectively regulate the level of inflammation in the circulation of patients with carotid atherosclerosis, improve lipid metabolism disorder, reduce inflammatory reaction, alleviate and stabilize plaque and resist atherosclerosis.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/amns-2024-0707

Reference23 articles.

1. LU Chaoyang, YAO Yao, GUO Chunling. Research progress of PCSK9 and atherosclerosis[J]. Hainan Medical Science, 2022,33(4):504-508.

2. WANG Mengnan, QIN Hewei, GUO Ning, et al. Progress of next-generation probiotics against atherosclerosis[J]. Chinese Journal of Comparative Medicine,2022,32(12):95-102.

3. WANG Minghao,MENG Ying. Research progress on endoplasmic reticulum stress and atherosclerosis[J]. Journal of Microcirculation,2023,33(1):97-101.

4. Zhai Yi. Progress of anti-atherosclerosis research on gibberellic acid in the past 10 years[J]. Primary Chinese Medicine,2023,2(4):121-124.

5. Expert consensus on the prevention and treatment of atherosclerosis in Chinese and Western medicine (2021) [J]. Chinese Journal of Integrative Medicine and Western Medicine, 2022, 42(03): 287-293.